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Introduction
Shock is deﬁ ned as global tissue hypoxia secondary to an 
imbalance between systemic oxygen delivery (DO2) and 
systemic oxygen demand (VO2). Unrecognised and 
untreated global tissue hypoxia increases morbidity and 
mortality. Accurate detection of global tissue hypoxia is 
therefore of vital importance. Physical ﬁ ndings, vital signs, 
measuring central venous pressure and urinary output are 
important but insuﬃ  cient for accurate detec tion of global 
tissue hypoxia [1-3]. Measurement of mixed venous 
oxygen saturation (SvO2) from the pulmo nary artery has 
been advocated as an indirect index of tissue oxygenation 
[4]. As a result of an extensive debate in the literature [5-7], 
however, use of the pulmonary artery catheter has become 
somewhat unpopular. In contrast, insertion of a central 
venous catheter in the superior vena cava via the jugular of 
the subclavian vein is considered standard care in critically 
ill patients. Just like SvO2, the measurement of central 
venous oxygen saturation (ScvO2) has been advocated in 
order to detect global tissue hypoxia.
Venous oxygen saturations have been the subject of 
research for over 50 years, but especially over the past 
decade the amount of literature describing changes in 
ScvO2 and SvO2 in critically ill patients, including high-risk 
surgical patients, increased substantially. Th is led to high 
expectations with respect to the use of venous oxygen 
saturation as a therapeutic goal. Th e aim of the present 
review is to summarise the evidence and to discuss the 
clinical utility of both SvO2 and ScvO2 in the treatment of 
critically ill patients, including high-risk surgical patients.
We performed a search of the PUBMED database from 
1980 to 2010 using combinations of the following terms: 
SvO2, ScvO2, venous oxygen saturation, venous satura-
tion, critically ill, shock, septic shock, high risk surgery, 
surgery, operation. Th e articles published in English were 
included when published in a peer-reviewed journal. Th e 
clinical investigations had to concern adults. Additionally, 
bibliographies of relevant articles were also screened.
Physiology
Understanding the physiology of venous saturations is 
essential for eﬀ ective application in critically ill patients 
and during the perioperative period.
Abstract
Shock is defi ned as global tissue hypoxia secondary to 
an imbalance between systemic oxygen delivery and 
oxygen demand. Venous oxygen saturations represent 
this relationship between oxygen delivery and oxygen 
demand and can therefore be used as an additional 
parameter to detect an impaired cardiorespiratory 
reserve. Before appropriate use of venous oxygen 
saturations, however, one should be aware of the 
physiology. Although venous oxygen saturation has 
been the subject of research for many years, increasing 
interest arose especially in the past decade for its 
use as a therapeutic goal in critically ill patients and 
during the perioperative period. Also, there has been 
debate on diff erences between mixed and central 
venous oxygen saturation and their interchangeability. 
Both mixed and central venous oxygen saturation are 
clinically useful but both variables should be used 
with insightful knowledge and caution. In general, 
low values warn the clinician about cardiocirculatory 
or metabolic impairment and should urge further 
diagnostics and appropriate action, whereas normal or 
high values do not rule out persistent tissue hypoxia. 
The use of venous oxygen saturations seems especially 
useful in the early phase of disease or injury. Whether 
venous oxygen saturations should be measured 
continuously remains unclear. Especially, continuous 
measurement of central venous oxygen saturation 
as part of the treatment protocol has been shown a 
valuable strategy in the emergency department and 
in cardiac surgery. In clinical practice, venous oxygen 
saturations should always be used in combination with 
vital signs and other relevant endpoints.
© 2010 BioMed Central Ltd
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SvO2 depends on arterial oxygen saturation (SaO2), the 
balance between VO2 and cardiac output (CO), and 
haemoglobin (Hb) levels. According to the Fick principle 
[8], SvO2 can be described by the following formula:
SvO2 = [SaO2 – VO2 / CO] [1 / Hb × 1.34]
Increased VO2 will be compensated by increased CO. If 
this is not adequate – that is, if oxygen demand is not 
met – elevated oxygen extraction occurs in the peripheral 
tissues and consequently SvO2 will drop. SvO2 thus reﬂ ects 
the balance between oxygen delivery and oxygen demand 
[9]. Th e normal range for SvO2 is 65 to 75% [4,10]. Low 
SvO2 is predictive of bad outcome [4,11], whereas normal 
or supranormal SvO2 (or ScvO2) values do not guarantee 
adequate tissue oxygenation [12,13]. If tissue is not capable 
of extracting oxygen (for example, in the case of shunting 
and cell death), venous return may have a high oxygen 
content despite persistent cellular hypoxia.
A variety of physiological and pathological changes 
may inﬂ uence venous saturation (Figure  1) and thus 
require diﬀ erent therapeutic interventions. Recognition 
of the aetiology of any derangement is obligatory for the 
safe use of venous saturation as a therapeutic goal.
Central versus mixed venous oxygen saturation
In general there has been considerable debate on equality 
or interchangeability of ScvO2 and SvO2 [14-16] (see 
Table 1). In critically ill patients, substituting SvO2 by 
ScvO2 results in large varia bility [16-21]. Th is could in 
part be explained by modiﬁ cations of blood ﬂ ow 
distribution and oxygen extrac tion by brain and 
splanchnic tissue. In this situa tion, ScvO2 may provide 
the false impression of adequate body perfusion. Also, 
whether a positive ScvO2–SvO2 gradient can be used as a 
marker of greater oxygen utilisation and a predictor of 
survival remains a subject of debate [20,22,23].
In contrast, other studies have stated that ScvO2 could 
indeed be used as a substitute for SvO2 [24-26]. For 
example, Reinhart and colleagues performed continuous 
measurements of venous oxygen saturations in anaes the-
tised dogs over a wide range of haemodynamic condi-
tions, including hypoxia, haemorrhage and resuscitation, 
and described close tracking between ScvO2 and SvO2 
[24]. However, correlation was lowest during hypoxia, 
one of the areas of greatest clinical interest. Nevertheless, 
precise determination of absolute values for SvO2 from 
ScvO2 was not possible, as was seen before [21,27-29].
Additionally, the relationship between CO or the 
cardiac index and venous saturations has been evaluated 
in criti cally ill patients. So far, the results have been 
inconclusive for both SvO2 and ScvO2. Larger trials are 
needed before clinical recommendations can be made 
regarding their clinical use [19,30-33].
Clinical use of venous oxygen saturations
Cardiac failure
Venous oxygen saturations have been shown to have 
diagnostic, prognostic, and therapeutic qualities in 
critically ill patients with acute myocardial infarction (see 
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Table 2). SvO2 was particularly reduced in patients with 
cardiogenic shock or left ventricular failure. Patients with 
cardiac failure are unable to increase CO during periods 
of increased oxygen need. Changes in oxygen demand 
will therefore only be compensated by changes in oxygen 
extraction in the same direction and indicated by inverse 
changes in venous oxygen saturations. Consequently, a 
drop in venous oxygen saturations will be a marker of 
Table 1. Studies comparing mixed venous oxygen saturation and central venous oxygen saturation
Study Design and subjects Results Conclusions
Varpula and 
colleagues [14]
n = 16; septic shock; ICU; 
72 paired samples
Mean SvO2 below mean ScvO2 at all time points; 
bias of diff erence 4.2%
95% limits of agreement –8.1 to 16.5%; diff erence 
correlated with CI and DO2
Diff erence between ScvO2 and SvO2 varied highly; 
SvO2 cannot be estimated on basis of ScvO2
Martin and 
colleagues [16]
n = 7; 580 comparative 
measurements; critically 
ill patients; ICU; with and 
without interventions
Diff erence ≥5% in 49% during periods of stability 
and in 50% during periods with therapeutic 
interventions
ScvO2 monitoring not reliable
Chawla and 
colleagues [17]
n = 32 postsurgical and 
n = 21 medical; ICU
SvO2 consistently lower than ScvO2 with mean 
(± SD) bias –5.2 ± 5.1%
SvO2 and ScvO2 not equivalent; substitution of 




n = 37; septic shock Mean SvO2 below mean ScvO2; mean bias –8.5%
95% limits of agreement –20.2 to 3.3%; this 
resulted in higher VO2 values
ScvO2 and SvO2 not equivalent in ICU patients 
with septic shock; substitution of ScvO2 for SvO2 in 
calculation of VO2 resulted in unacceptably large 
errors
Ho and colleagues 
[19]
n = 20; cardiogenic or septic 
shock
ScvO2 overestimated SvO2 with mean bias 6.9%; 
95% limits of agreement –5.0 to 18.8%; changes of 
ScvO2 and SvO2 did not follow the line of perfect 
agreement
ScvO2 and SvO2 are not interchangeable 
numerically
van Beest and 
colleagues [20]
n = 53; 265 paired samples; 
sepsis; ICU; multicentre
Mean SvO2 below mean ScvO2 at all time points; 
bias of diff erence 1.7%
95% limits of agreement –12.1 to 15.5%; identical 
results for change in ScvO2 and SvO2
Distribution of (ScvO2 – SvO2) (<0 vs. ≥0) similar in 
survivors and nonsurvivors
ScvO2 does not reliably predict SvO2 in patients 
with sepsis
Trend of ScvO2 not superior in this context




n = 24; critically ill cardiac 
patients; CCU
ScvO2 levels in superior vena cava are greater 
than SvO2 in shock (58 ± 13 vs. 47.5 ± 15; r = 0.55); 
changes in ScvO2 refl ect changes in SvO2 
(r = 0.90); ScvO2 from right atrium is similar to SvO2 
(49.2 ± 19 vs. 49.2 ± 19; r = 0.96)
SvO2 consistently lower than ScvO2
Poor correlation in heart failure or shock
Changes in ScvO2 refl ect changes in SvO2
Dueck and 
colleagues [25]
n = 70; 502 comparative sets; 
neurosurgery
95% limits of agreement ranged from 6.8% to 
9.3% for single values
Correlations between changes of SvO2 and ScvO2: 
r = 0.755, P <0.001
Numerical ScvO2 values not equivalent to SvO2 in 
varying haemodynamic conditions; trend of ScvO2 
may be substituted for the trend of SvO2
Reinhart and 
colleagues [26]
n = 32; critically ill patients; 
ICU; continuous parallel 
measurements
ScvO2 closely paralleled SvO2, in vitro r = 0.88 and 
in vivo r = 0.81
ScvO2 averaged (± SD) 7 ± 4% higher than SvO2
ScvO2 changed in parallel in 90% when SvO2 
changed more than 5%
Continuous fi breoptic measurement of ScvO2
Potentially reliable tool to rapidly warn of acute 
change in the oxygen supply/demand ratio
Ladakis and 
colleagues [28]
n = 31 surgical and n = 30 
medical; critically ill patients; 
ICU
Signifi cant diff erence between mean ScvO2 and 
SvO2 (69.4 ± 1.1 vs. 68.6 ± 1.2%); r = 0.945 for total 
population
ScvO2 and SvO2 are closely related and 
interchangeable for initial evaluation
Tahvanainen and 
colleagues [29]
n = 42; critically ill patients; 
ICU; ScvO2 as representative 
of real changes in pulmonary 
shunt
Signifi cant correlation between measured 
variables between PA blood samples and both 
superior vena cava and right atrial blood samples 
(P <0.001)
ScvO2 can replace SvO2; exact SvO2 value can only 
be measured from the PA itself
CCU, cardiac care unit; CI, cardiac index; DO2, oxygen delivery; PA, pulmonary artery; ScvO2, central venous oxygen saturation; SvO2, mixed venous oxygen saturation; 
VO2, oxygen consumption.
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Table 2. Studies describing central venous oxygen saturation in clinical settings
Study Design and subjects Results Conclusions
Rady and 
colleagues [1]
n = 36; critically ill patients; ED Additional therapy is needed after haemodynamic 
stabilisation to normal blood pressure and heart rate




n = 619 registries treated with 
EGDT; observational study
Groups: ScvO2 <70%, ScvO2 71 to 89%, ScvO2 >90%
Multivariate analysis: initial high ScvO2 higher mortality




Controls n = 17, high lactate 
group n = 22, low lactate group 
n = 5; chronic congestive heart 
failure; ED
ScvO2 lower in high lactate group than in low lactate 
group (32 ± 12% vs. 51 ± 13%) and control (60 ± 6%); 
after treatment
There was a signifi cant decrease of lactate and 
increase in ScvO2 in the high lactate group compared 
with the low lactate group
Once patients with decompensated end-
stage congestive heart failure are identifi ed, 




n = 26, trauma patients with 
suggested blood loss
Despite stable vital signs, 39% of the patients 
had ScvO2 <65%; these patients required more 
transfusions; linear regression analysis demonstrated 
superiority of ScvO2 to predict blood loss compared 
with normally allowed parameters
ScvO2 is a reliable and sensitive method for 
detecting blood loss; it is a useful tool in the 
evaluation of acutely injured patients
Di Filippo and 
colleagues [41]
n = 121 brain injury after 
trauma; noncontrolled study
Nonsurvivors showed higher lactate, lower ScvO2 
values; patients with ScvO2 ≤65% showed higher 28-
day mortality, ICU LOS and hospital LOS than patients 
with ScvO2 >65%
ScvO2 <65% in fi rst 24 hours after admission 
in patients with major trauma and head 
injury is associated with prolonged 
hospitalisation and higher mortality
Pearse and 
colleagues [65]
n = 118, major surgery After multivariate analysis, lowest CI and lowest ScvO2 
were associated with postoperative complications; 
optimal ScvO2 cut-off  value for morbidity prediction 
was 64.4%; in the fi rst hour after surgery, signifi cant 
reductions in ScvO2 were observed, without signifi cant 
changes in CI or oxygen delivery index
Results suggest that oxygen consumption 
is also an important determinant of ScvO2; 
reductions in ScvO2 are independently 
associated with postoperative complications
Rivers and 
colleagues [73]
n = 263; RCT; EGDT vs. controls; 
severe sepsis, septic shock; ED
EGDT (goal: ScvO2 ≥70%) showed better survival 
(absolute 16%), lower lactate; more fl uids, red cell 
transfusion and inotropics
EGDT provides benefi ts to outcome
Trzeciak and 
colleagues [74]
n = 16 pre-EGDT; n = 22 EGDT Less PAC utilisation; more fl uids and dobutamine used; 
similar costs
EGDT endpoint can reliably be achieved
Kortgen and 
colleagues [75]




Implementation: use of dobutamine, insulin, 
hydrocortisone and activated protein C increased
Amount of fl uids and packed blood cells unaff ected
Mortality signifi cantly lower after implementation 
(27% vs. 53%; P < 0.05).




n = 79 pre-intervention; n = 77 
post-intervention; ED
Controls: more renal failure at baseline
Greater crystalloid volume and vasopressor infusion
Mortality 18 vs. 27%




n = 60 before implementation 
order set; n = 60 after 
implementation order set; ED
More appropriate antimicrobial regimen
More fl uids, more vasopressors





n = 51 historical controls; n = 79 
septic shock
Patients received more fl uids, earlier antibiotics, more 
vasopressors, tighter glucose control, more frequent 
assessment of adrenal function, not more packed 
blood cells
Implementation sepsis protocol feasible
No survival benefi t
Jones and 
colleagues [94]
Multicentre, randomised; n = 
300 severe sepsis, septic shock
Goals: lactate clearance vs. 
ScvO2
Higher in hospital mortality ScvO2; nonsignifi cant 
diff erence (predefi ned –10% threshold)
No signifi cantly diff erent in-hospital 
mortality between normalisation of lactate 
clearance compared with normalisation 
ScvO2
CI, cardiac index; ED, emergency department; EDGT, early goal-directed therapy; LOS, length of stay; PAC, pulmonary artery catheter; RCT, randomised controlled trial; 
ScvO2, central venous oxygen saturation.
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cardiac deterioration. Patients with low venous oxygen 
satura tions in the early disease stage may be considered 
in shock [34,35]. Also, patients with sepsis and known 
decreased left ventricular function seem to beneﬁ t from 
early goal-directed therapy (EGDT) when treated for 
sepsis [36] according to the Surviving Sepsis Campaign 
guidelines [37]. Finally, in the setting of cardiopulmonary 
resusci tation, a ScvO2 of 72% is highly predictive for 
return of spontaneous circulation [38].
Trauma
In the initial assessment of trauma patients, an adequate 
judgement of possible blood loss is essential. Compared 
with conventional parameters, venous oxygen saturations 
are superior in predicting blood loss [39,40]. Moreover, 
after major trauma with brain injury, ScvO2 values below 
65% in the ﬁ rst 24 hours are associated with higher 
mortality (28-day mortality 31.3% vs. 13.5%) and pro-
longed hospitalisation (45 days vs. 33 days) [41].
High-risk surgery
In cardiac surgery patients, SvO2 has been shown to be 
superior to the mean arterial pressure and heart rate as a 
qualitative warning sign of substantial haemodynamic 
deterioration. However, results on the predictive value of 
SvO2 for CO in clinical settings are inconsistent [42-44]. 
Nevertheless, continuous SvO2 monitoring enables the 
early diagnosis of occult bleeding or could show poor 
tolerance of a moderate anaemia due to the inability of 
the patient with chronic heart dysfunction or pre-
operative negative inotropic treatment (for example, β-
blockers) to increase CO in the face of anaemia. Further-
more, temporary decreases of SvO2 values after cardiac 
surgery are of prognostic value and may predict the 
development of arrhythmias [45-47]. Also, probably due 
to an increased oxygen extraction ratio, decreased SvO2 
values during weaning from mechanical ventilation are 
predictive for extubation failure [48-50]. Finally, good 
predictive values of SvO2 for mortality have been 
described [51,52]. Th is suggests beneﬁ cial eﬀ ects of SvO2 
monitoring, at least during and after cardiac surgery.
Goal-directed therapy has been shown to improve 
outcome after major general surgery [53]. Originally, the 
goals in the protocol group were supranormal haemo-
dynamic and oxygen transport values (cardiac index 
>4.5  l/minute/m2, DO2 >600 ml/minute/m2, VO2 
>170 ml/minute/m2). In this group a signiﬁ cant reduction 
of complications, hospital stay, duration of mechanical 
ventilation and mortality was achieved when the pulmo-
nary artery catheter was placed preoperatively [54]. Such 
a strict predeﬁ ned concept holds certain risks, however, 
and should not be translated to all patients [55-57]. Meta-
analyses of haemodynamic optimisation in high-risk 
patients revealed haemodynamic optimisation to be 
beneﬁ cial only when interventions were commenced 
before development of organ failure [58,59]. Several of 
the studies described showed improved outcome, possibly 
including long-term survival, when goal-directed therapy 
was commenced before surgery [54,60-62]. Perhaps 
owing to methodological short com ings, a multicentre 
trial that randomised surgical patients to pulmonary 
artery catheter guided or conventional management 
failed to show a diﬀ erence in outcome [63,64]. More 
recently a reduction in postoperative complications and 
duration of hospital stay was described when goal-
directed therapy was used postoperatively [65-67]. 
However, the above mentioned ﬁ ndings do not provide 
deﬁ nite answers on how to use venous saturations as a 
therapeutic goal. Only one interventional trial used 
ScvO2 as a therapeutic goal in perioperative care [68]. In 
this study the intervention group received therapy to 
achieve an estimated oxygen extraction ratio <27% after 
predeﬁ ned goals for arterial pressure, urine output, and 
central venous pressure had been achieved. Fewer 
patients developed organ failure in the ScvO2 group 
[68].
Sepsis and septic shock
In a large multicentre study, three diﬀ erent cohorts of a 
very heterogeneous population of critically ill patients 
were compared for survival after diﬀ erent strategies for 
haemodynamic therapy had been applied: control versus 
supranormal values for the cardiac index (>4.5 l/minute/m2) 
or normal values for mixed venous saturation. In total, 
the anticipated goal was only achieved in one-third of the 
patients. Th ere was no signiﬁ cant reduction in morbidity 
or mortality in any group [69]. An important reason for 
this may be the late timing of the intervention (that is, 
after occurrence of organ failure), implying that all 
patients suﬀ ered severe damage and received signiﬁ cant 
treatment before inclusion.
Global tissue hypoxia as a result of systemic inﬂ am-
matory response or circulatory failure is an important 
indicator of shock preceding multiple organ dysfunction 
syndrome. Th e development of multiple organ dysfunc-
tion syndrome predicts the outcome of the septic patient 
[37]. Treatment strategies aimed at restoring the balance 
between DO2 and VO2 by maximising DO2 have not been 
successful [57,69,70].
In line with studies over several decades [1,21,27, 
35,40,71] and based on recommendations [72], Rivers 
and colleagues randomised 263 patients with severe 
sepsis or septic shock to standard therapy or EGDT. 
Compared with the conventionally treated group, the 
ScvO2 guided group received more ﬂ uids, more fre-
quently dobutamine, and more blood transfusion during 
the ﬁ rst 6 hours. Th is resulted in an absolute reduction in 
28-day mortality of 16% [73].
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A large number of studies that implemented certain 
treatment protocols in the emergency department – 
including antibiotic therapy and tight glucose control, for 
example [74-79] – showed a signiﬁ cant decrease in 
mortality. EGDT endpoints (central venous pressure 8 to 
12 mmHg, mean arterial pressure ≥65 mmHg, and ScvO2 
≥70%) can well be achieved in an emergency department 
setting, suggest ing that a multifactor approach is a useful 
strategy in the treatment of sepsis [74-80]. Of note, three 
of these studies described similar populations with a high 
percen tage of end-stage renal disease in the control 
group being prone for higher mortality [76,77,79,81]. 
Although attainment of ScvO2 >70% has been reported as 
a prominent factor for survival [82], several studies that 
used EGDT without this speciﬁ c target were also able to 
achieve a survival beneﬁ t [83-85]. In summary, as shown 
by Nguyen and colleagues [86], the use of (modiﬁ ed) 
EGDT implies early recognition of the critically ill patient 
and enforces continuous reassessment of treatment. Th is 
observation seems to be the greatest gain in the treatment 
of patients with severe sepsis or septic shock over the 
past decade.
Earlier studies that enrolled patients admitted to the 
ICU were unable to show a decrease in mortality after 
aggressive haemodynamic optimisation [57,69]. In con-
trast, more recent studies that used modiﬁ ed EGDT 
proto cols were able to show a signiﬁ cant decrease in 
mortality [85,87,88], suggesting that compliance to 
dedicated sepsis bundles after the emergency department 
stage can still be useful.
Low incidences of low ScvO2 values at ICU admission 
[89] or emergency department presentation [90] do occur 
together with baseline mortality, however, com pared 
with the original EGDT study [73,89,90]. For clinical 
appreciation of the above-mentioned results, a thorough 
look into the data is needed. Interestingly, fewer patients 
were intu bated before the ﬁ rst ScvO2 sampling in the 
EGDT study [73], and this could partially explain the 
diﬀ erence of initial ScvO2 values between both studies 
[73,89]: due to higher DO2 (pre-oxygenation) and lower 
VO2 (sedation, paralysis; lower work of breathing), ScvO2 
may very well improve in response to emergency 
intubation in the majority of patients [91]. Th is 
hypothesis partially explains the diﬀ erences between 
populations [73,89,90] and provides another piece in the 
puzzle on the value of ScvO2 [92]. Nevertheless, 
applicability of the results of the EGDT trial may be 
dependent on the geographical setting and the underlying 
healthcare system [92,93].
Additionally, no diﬀ erence in outcome was found 
between a resuscitation protocol based on lactate clear-
ance and a ScvO2-based protocol [94], and ScvO2 optimi-
sation does not always exclude a decrease in lactate levels 
[95]. Also, the pursuit of ScvO2 >70% does not always 
seem to be the optimal solution. Recent data suggest that 
patients with initially high ScvO2 values may also have 
adverse outcomes [12,13], probably due to impaired 
oxygen utilisation. High ScvO2 values may thus represent 
an inability of the cells to extract oxygen or micro-
circulatory shunting in sepsis [96].
Finally, as a reﬂ ection of an increased respiratory 
muscle oxygen extraction ratio, a reduced ScvO2 or SvO2 
predicts extubation failure in diﬃ  cult-to-wean patients 
[48,97]. However, a successful intervention to increase 
ScvO2 in this context is not yet known. Nevertheless, it is 
conceivable that in the future ScvO2 will be used as a 
parameter in weaning protocols for a subset of patients 
[97,98].
Continuous measurement
Should continuous measurement be considered when 
venous saturations are used as a therapeutic goal? It may 
be argued that changes in venous saturations may occur 
rapidly, particularly in haemodynamically instable patients, 
and that discontinuous spot measurements by drawing 
intermittent blood samples may miss these changes. 
Accordingly, continuous measurement of SvO2 in septic 
shock patients revealed a higher frequency of short-term 
changes in SvO2 in nonsurvivors. Variations in SvO2 
could thus be of prognostic importance [99]. However, 
the lack of therapeutic guidelines and cost-eﬀ ectiveness 
issues question the clinical use of continuous measure-
ment of SvO2 in critically ill patients [5,7,58]. Continuous 
measurement in perioperative care allows detection of 
ﬂ uctuations. Low SvO2 values have been associated with 
increased complications and morbidity, especially in 
cardiac surgery [100]. Th e use of SvO2 values >70% as a 
target seems promising in cardiac surgery and during 
cardiopulmonary resuscitation [38,43].
Th ere are currently two commercially available devices 
to measure ScvO2 continuously. Continuous ScvO2 
measurement as part of treatment protocol has shown to 
be a valuable strategy in the emergency department 
[71,73] and in cardiac surgery [101]. Additionally, Rein-
hart and colleagues concluded that continuous ScvO2 
measurement in the ICU setting is potentially reliable 
[26]. However, continuous and intermittent measure-
ments of SvO2 or ScvO2 have never been compared 
systematically.
Conclusions
Th e ongoing debate on diﬀ erences between SvO2 and 
ScvO2 and their interchangeability should focus on well-
deﬁ ned populations. SvO2 and ScvO2 are clinically useful 
but both variables should be used with knowledge and 
caution. Evaluating the available evidence in a clinical 
setting, we conclude that low venous oxygen saturations 
are an important warning sign for the inadequacy of DO2 
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to meet oxygen demands. Low values may warn the 
clinician about cardiocirculatory or metabolic impair-
ment and should urge for further diagnostics and appro-
priate action, whereas normal or high values do not rule 
out persistent tissue hypoxia. Based on the numerous 
clues for its usefulness discussed in this article, the use of 
venous oxygen saturations seems especially useful in the 
early phase of disease or injury. In clinical practice, 
venous oxygen saturations should always be used in 
combination with vital signs and other relevant 
endpoints.
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